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 Abstract    
Objectives: In the case of carcinogenesis in human endometrium no information exists on tissue concentration of 
8-oxo-7,8-dihydroguanine, the DNA oxidative stress marker. This was the main reason to undertake the investiga-
tion of this DNA modification in human uterine estrogen-dependent tissue cancers. 
Material and Methods: In order to estimate the level of oxidative damage, 8-oxo-7,8-dihydroguanine was deter-
mined directly in cells of tissue microscope slides using OxyDNA Assay Kit, Fluorometric. Cells were investigated 
under confocal microscope. Images of individual cells were captured by computer-interfaced digital photography 
and analyzed for fluorescence intensities (continuous inverted 8-bit gray-scale = 0 [black]-255 [white]). Fluorescen-
ce scores were calculated for each of 13 normal endometrial samples and 31 uterine adenocarcinoma specimens. 
Finally, the level of the oxidative stress marker was also analyzed according to histological and clinical features of 
the neoplasms. 
Results: The obtained data revealed that: 8-oxo-7,8-dihydroguanine levels were higher in uterine adenocarcino-
mas than in normal endometrial samples (48,32 vs. 38,64; p<0,001);  in contrast to normal endometrium there was 
no correlation between age and DNA oxidative modification content in uterine cancer; highest mean fluorescence 
intensity was recognized in G2 endometrial adenocarcinomas; level of 8-oxo-7,8-dihydroguanine does not depend 
on Body Mass Index (BMI) and cancer uterine wall infiltration or tumor FIGO stage.
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Introduction
Endometrial	cancer	is	the	most	frequently	recognized	malig-
nancy	of	the	female	genital	tract	[1].	Most	of	diagnosed	uterine	
tumors	are	adenocarcinomas	which	are	believed	to	be	estrogen-
dependent	 [2].	 It	 is	 widely	 accepted	 that	 in	 human	 uterine	 or	
mammary	hormone-dependent	carcinogenesis	estrogens	act	not	
only	as	tumor	promoters	but	also	as	carcinogens	[3,	4].	Such	a	
steroid	carcinogenic	action	 is	 strongly	connected	with	metabo-
lism	of	catechols/o-quinones	which	is	a	source	of	overwhelming	
amounts	 of	 reactive	 oxygen	 species	 (ROS)	 that	 generate	DNA	
oxidized	lesions	which,	in	turn,	may	lead	to	gene	mutation,	and	
in	the	next	steps,	to	neoplastic	cell	transformation	[4].	
Among	 more	 than	 30	 oxidative	 DNA	 adducts	 that	 have	
been	characterized,	one	is	8-oxo-7,8-dihydro-2’-deoxyguanosine	
(8-oxodG),	 and	 its	 corresponding	base	 is	 8-oxo-guanine	which	
is	suspected	to	be	a	factor	that	contributes	to	cancer	by	genomic	
instability	increase	[5,	6,	7].	It	was	recognized	that	8-oxodG	could	
be	a	source	of	GC→TA	transversions	in	the	ras	oncogene	and	the	
p53	 tumor	suppressor	gene	 in	 lung	and	 liver	cancers	 [8].	Such	
mutations	were	 recognized	 in	 endometrial	 adenocarcinomas	 in	
10-30%	and	5%,	respectively	[9,	10].	
It	has		also	been	postulated	recently	that	8-oxoG	DNA	lesion	
located	 adjacent	 to	 the	 target	 cytosine	may	markedly	 diminish	
productive	versus	nonproductive	binding	of	DNA	(cytosine-5-)-
methyltransferase	 3	 alpha	 to	DNA,	 thus	 favoring	 formation	 of	
aberrant	DNA	methylation	patterns	during	carcinogenesis	[7].	
In	 estrogen-dependent	 tissues	 the	 rate	 of	 oxidative	 DNA	
damage	may	be	probably	increased	by	estrogen	receptor	“Trojan	
horse”	mechanism	[11,	12].	This	mode	of	action	possibly	involves	
translocation	of	 catechol	 forms	of	 estrogens	 and/or	o-quinones	
bound	to	estrogen	receptors	to	steroid	sensitive	genes	where	DNA	
damage	occurs	resulting	in	mutations.	Indeed,	Musarrat	et	al.	[13]	
revealed	that	in	human	breast	carcinogenesis	estrogen	receptor-
positive	neoplastic	 tissue	 contained	 a	 significantly	higher	 level	
of	8-oxodG	than	in	estrogen	receptor-negative	cancer	specimens.	
Furthermore,	in	this	research	8-oxodG	was	found	to	be	positively	
correlated	with	the	amount	of	estrogen	binding	sites.
It	 was	 also	 suggested	 	 that	 high	 levels	 of	 oxidative-stress	
derived	 DNA	 lesions	 preceded	 oncogenic	 transformation	 [3].	
Such	relationship	was	revealed	by	Shimoda’s	group	 in	humans	
where	 liver	 tissue	 with	 chronic	 hepatitis,	 which	 may	 lead	 to	
hepatocellular	carcinoma,	contained	significantly	more	8-oxodG	
than	normal	livers	[14].	A	higher	amount	of	8-oxodG	adduct	in	
uterine	myomas	that	may	precede	uterine	sarcomas,	in	contrast	
to	 disease-free	 surgical	 margin,	 was	 recognized	 in	 women	 by	
Foksinski	 et	 al.	 [15].	Moreover,	 they	 discovered	 that	 8-oxodG	
levels	were	proportional	to	tumor	volume.
In	addition	to	this,	Ohno	et	al.	revealed	that	distribution	of	
8-oxo-7,8-dihydroguanine	in	the	steady-state	correlates	with	the	
preferred	regions	for	recombination	and	single	polymorphism	in	
the	human	genome	and,	 according	 to	 the	opinion	presented	by	
this	 group	of	 authors,	 oxidized	DNA	adduct	 contributes	 to	 the	
genomic	diversity	in	human	beings	[16].
In	human	endometrium	carcinogenesis	no	information	exists	
on	 tissue	 concentration	 of	 8-oxo-7,8-dihydroguanine	 which	 is	
recognized	as	DNA	oxidative	stress	marker.	This	was	the	main	
reason	to	undertake	the	investigation	of	 this	DNA	modification	
in	 human	 uterine	 estrogen-dependent	 tissue	 cancers.	 Using	
fluorometric	method	 oxidized	 DNA	 lesions	 were	 quantified	 in	
13	normal	endometrial	samples	and	31	uterine	adenocarcinoma	
specimens.	 Finally,	 the	 level	 of	 8-oxoGua	 was	 also	 analyzed	
according	to	histological	and	clinical	features	of	the	neoplasms.	
The	methods	used	 enabled	us	 to	 recognize	 specific	patterns	 of	
8-oxo-7,8-dihydroguanine	 distribution	 within	 the	 investigated	
cells	nuclei,	as	well.
Conclusions: Our study indicates that accumulation of the oxidized DNA base may contribute to the development 
of endometrial neoplasia, however, oxidative DNA damage does not seem to increase with tumor progression. 
 Key words: oxidative stress / 8-oxoguanine / sporadic uterine adenocarcinomas / 
        / fluorescence image analysis /
 Streszczenie 
Materiał i metody: Stosując komercyjny zestaw OxyDNA Assay Kit, Fluorometric, przy użyciu mikroskopu 
konfokalnego oceniono w jednostkach 8-bitowej skali szarości natężenie fluorescencji generowanej przez 8-oksy-
7-8 dwuhydroguaninę jąder komórkowych gruczolakoraka błony śluzowej macicy u kobiet. 
Wyniki: Jądra komórek utkania nowotworowego w relacji do jąder komórek z prawidłowej błony śluzowej macicy 
zawierały wyższy poziom markera stresu oksydacyjnego. W przeciwieństwie do prawidłowego endometrium, w 
tkankach nowotworu nie zanotowano korelacji między wiekiem chorej a poziomem 8-oksy-7-8 dwuhydroguaniny, 
który był najwyższy w nowotworach w stopniu G2. Poziom markera nie był zależny od indeksu BMI, głębokości 
naciekania ściany macicy przez nowotwór, czy też stopnia FIGO. 
Wnioski: Przeprowadzone badania wskazują, że stres oksydacyjny DNA może brać udział w nowotworzeniu 
w endometrium, jakkolwiek jego nasilenie prawdopodobnie nie jest uzależnione od progresji guza.
 Słowa kluczowe: stres oksydacyjny / 8-oksyguanina / sporadyczne gruczolakoraki 
       błony śluzowej macicy / fluorescencyjna analiza obrazu /
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Materials and methods
The	 study	 group	 consisted	 of	 31	 uterine	 adenocarcinoma	
patients	 who	 underwent	 total	 abdominal	 hysterectomy	 and	
bilateral	 salpingo-oophorectomy	 at	 the	 2nd	 Department	 of	
Gynecology,	 Medical	 University	 of	 Lublin,	 Lublin,	 Poland.	A	
written	informed	consent	was	obtained	in	each	case	enrolled	in	
this	study.	The	age	range	of	investigated	women	was	43-85	years	
(mean	 ±SEM	 63.6±1.7).	 All	 cases	 were	 considered	 sporadic	
since	none	of	cancer	affected	women	met	the	Amsterdam	criteria	
[17]	 for	 hereditary	 non-polyposis	 colon	 cancer	 syndrome.	
Histopathological	examination	of	each	collected	neoplasm	tissue	
specimen	was	performed	at	Pathology	Department	according	to	
WHO	staging	system	[18].	
All	 specimens	 were	 assessed	 as	 endometrioid-type	
endometrial	 carcinomas.	 There	 were	 12	 well-differentiated	
(grade	1),	14	moderately-differentiated	(grade	2)	and	5	poorly-
differentiated	(grade	3)	tumors.	Seventeen	neoplasms	infiltrated	
uterine	 wall	 for	 less	 than	 half	 of	 its	 thickness,	 whereas	 14	
cancers	displayed	deeper	myometrial	invasion.	Nineteen	tumors	
were	 classified	 as	 stage	 I	 ,	 nine	 as	 stage	 II	 and	 three	 as	 stage	
III	according	to	FIGO	surgical	staging	system	[19].	For	further	
analysis	 uterine	 cancers	 categorized	 into	 stage	 II	 and	 III	 were	
combined	as	clinically	more	advanced	adenocarcinomas.
The	 control	 group	 consisted	 of	 13	 normal	 endometrial	
tissue	specimens	obtained	during	total	abdominal	hysterectomy	
performed	due	 to	benign	uterine	 lesions.	The	mean	age	of	 this	
group	was	44.5±2.4	(SEM)	(range	32-50).
After	 uterus	 removal,	 the	 uterine	 corpus	 was	 gently	 cut	
from	 the	 fundus	 toward	 internal	 os	 	 of	 cervical	 canal	 to	 avoid	
any	 contamination	 of	 uterine	 cavity	 with	 endocervical	 cells.	
Opened	uterine	cavity	was	 then	washed	twice	with	cold	(4	˚C)	
physiological	 saline	 solution	 to	 remove	 blood	 clots	 or	 uterine	
discharge.	 The	 tissue	material	 was	 then	 immediately	 collected	
into	sterile	Eppendorf	tubes	under	loupe	magnification	(5x)	using	
punch	biopsy	forceps.	All	tissue	samples	were	quickly	frozen	and	
stored	in	liquid	nitrogen.	
8-oxo-7,8-dihydroguanine determination
Estimation	 of	 8-oxo-7,8-dihydroguanine	 was	 performed	
using	 OxyDNA	 Assay	 Kit,	 Fluorometric	 (Cat.	 No.	 500095)	
supplied	by	Calbiochem.
In	 the	first	 step	of	analysis	 tissue	 specimens	were	cut	at	8	
μm	thin-sections	and	subjected	to	adhesion	onto	silanized	glass	
slides	(DakoCytomation)	by	baking	(16	h,	56	˚C).	Tissue	slides	
rehydrated	through	serial	bath	going	from	absolute	to	70%	ethanol	
solution	were	then	placed	in	0.2	N	HCl	and,	after	washing	with	
distilled	water,	were	 further	 incubated	 for	30	min	 in	preheated	
to	80	˚C	Pretreatment	Solution	supplied	to	Paraffin	Pretreatment	
Kit	(Vysis).	After	incubation,	tissue	slides	were	treated	for	next	
30	min	at	37	˚C	with	protease	solution.	Further,	 tissue	sections	
were	fixed	in	4%	formaldehyde	for	10	min	at	room	temperature	
and	after	 rinsing	 in	Rinsing	Buffer	 (Calbiochem)	were	dried	at	
45-50°C	for	5	min.
In	the	next	step	tissue	slides	were	dehydrated	by	dipping	in	
cooled	 (-20°C)	 solutions	 containing	 increasing	 concentrations	
(from	 70	 to	 99%)	 of	 methanol	 and	 after	 rinsing	 in	 500	 μl	 of	
Rinsing	 Solution	 specimens	were	 subjected	 to	 incubation	with	
Blocking	 Solution.	 That	 step	 eliminates	 non-specific	 binding	
of	 FITC-Conjugate	 containing	 8-oxo-7,8-dihydroguanine	
monoclonal	 antibody	 conjugated	 to	 fluorescein	 isothiocyanate	
which	was	added	onto	tissue	slides	in	the	next	step	of	procedure.	
After	 removal	of	FITC	conjugate	and	rinsing	 in	distilled	water	
(5x)	all	slides	were	covered	with	a	glass	microscope	coverslip.	
For	each	prepared	tissue	slide,	images	of	25	randomly	chosen	
nuclei	located	on	slide’s	diagonal	were	captured	using	confocal	
microscope	LSM	5	PASCAL	(Zeiss,	Germany)	equipped	with	the	
software	version	3.0.
To	 quantify	 8-oxo-7,8-dihydroguanine	 amount	 in	 every	
investigated	nucleus,	we	cut	 eleven	optical	 slices,	 every	 single	
separated	 by	 0.8	 μm,	 using	 2000x	 magnification	 (objective	
100x,	 Immersion-Oil,	Apochromat,	 and	digital	 crop	2x;	Figure	
1,	Figure	2).
All	 captured	 images	 of	 investigated	 nuclei	 were	 analyzed	
for	fluorescent	intensity	in	an	8-bit	grey-scale	unit	using	ImageJ	
software	version	1.33a	(Wayne	Rasband	NIH,	USA).	The	mean	
value	of	background	fluorescence,	i.	e.	generated	by	areas	located	
in	the	vicinity	of	the	investigated	nucleus,	was	subtracted	from	
the	total	value	of	each	nucleus	fluorescent	intensity	to	get	a	real	
value	of	8-oxo-7,8-dihydroguanine	signal.
Descriptive	statistics,	mean,	median,	standard	error	of	mean	
and	 range	values	were	 calculated	 from	 the	units	 of	fluorescent	
intensity	expressed	in	an	8-bit	grey-scale.	An	individual	level	of	
fluorescence	of	each	tissue	slide	corresponds	to	a	mean	calculated	
from	the	total	amount	of	fluorescent	intensity	of	25	investigated	
nuclei	 as	 described	 above.	The	 difference	 between	means	was	
calculated	 using	 u	 Mann-Whitney	 test.	 Correlation	 analyses	
were	 performed	 by	 applying	 the	 Spearman’s	 rank	 correlation	
test.	 Statistica	 9	 software	 for	Windows	 [StatSoft,	 Inc.	 (2009).	
STATISTICA	(data	analysis	software	system),	version	9.0.	www.
statsoft.com.]	was	used	and	the	 level	of	significance	was	set	at	
p<0.05.	Data	are	expressed	as	means	±SEM.	
Results
Our	 investigation	 revealed	 the	 presence	 of	 8-oxo-7,8-
dihydroguanine	 in	 both	 normal	 and	 neoplasmatic	 endometrial	
tissue.	There	were	 interindividual	 substantial	differences	 in	 the	
amount	of	oxidized	base	not	only	in	adenocarcinomas	but	also	in	
disease-free	tissue	specimens	as	indicated	by	range	and	median	
level	of	fluorescent	intensity	(Table	I).
The	 highest	 variations	 of	 8-oxo-7,8-dihydroguanine	 level	
were	 noted	 in	 secretory	 endometrium	 in	 which	 the	 maximum	
value	 of	 fluorescence	 was	 10	 fold	 higher	 than	 the	 lowest	 one	
(7.98	 vs.	 79.19).	 In	 contrast,	 in	 adenocarcinomas	 group	 that	
value	was	 amounted	 to	 about	 4	 (31.92	 vs.	 126.9)	 and	was	 the	
highest	in	G2	tumors.	However,	the	lowest	value	of	fluorescent	
intensity	in	cancers	was	about	3	fold	higher	than	it	was	revealed	
in	noncancerous	endometrial	tissue	(7.98	vs.	23.93).
Table  I .  Range and median level in units of [8-bit] grey-scale of  
8-oxo-7,8-dihydroguanine in human endometrium.
Endometrial histology range median
Normal endometrium
n=13 7.98 – 79.19 32.9
Adenocarcinoma
n=31 23.93 – 126.9 39.05
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There	 were	 no	 differences	 between	 mean	 oxidative	 DNA	
adduct	 level	 in	 proliferative	 and	 secretory	 endometrium	
(37.99±5.16	 vs.	 37.45±10.1).	 In	 normal	 endometrium	 there	
was	a	significant,	positive	correlation	between	DNA	8-oxo-7,8-
dihydroguanine	level	and	patient’s	age	along	with	no	relation	to	
BMI	(R=0.47,	p=0.028;	R=	-0.04,	p=0.85,	respectively).
The	 mean	 8-oxoGua	 amount	 in	 uterine	 adenocarcinomas	
was	 significantly	 higher	 than	 it	 was	 recognized	 in	 normal	
endometrium	(48.32±4.23	vs.	35.66±5.01;	p<0.001),	(Figure	3).	
There	were	no	correlations	between	8-oxoGua	content	and	age	or	
BMI	of	cancer	affected	women.	
A	 mean	 oxidized	 DNA	 adduct	 level	 in	 cancers	 divided	
according	to	WHO	classification	was	higher	than	in	noncancerous	
endometrium	 in	 every	 tumor	 grade	 group,	 however	 in	 G1	
adenocarcinomas	it	was	not	statistically	significant	(Figure	4).
The	 highest	 mean	 8-oxo-7,8-dihydroguanine	 level	 was	
recognized	in	G2	neoplasms	(58.41±7.56).	That	was	significantly	
higher	 than	 it	 was	 revealed	 in	 G1	 (39.24±3.71)	 and	 G3	
(41.81±9.5)	 tumors	 (p<0.0001;	 p<0.000002,	 respectively).	 A	
mean	8-oxoGua	amount	in	G3	neoplasms	was	higher	than	it	was	
recognized	in	G1	endometrial	cancers	(p<0.0001).	There	were	no	
differences	in	8-oxo-7,8-dihydroguanine	amount	between	tumors	
confined	to	endometrial	mucosa	or	invading	myometrium	for	less	
than	half	of	its	thickness	and	neoplasms	displaying	deeper	uterine	
wall	 invasion	 (50.78±6.05	 vs.	 45.32±5.97;	 p=0.32).	 In	 uterine	
adenocarcinomas	classified	according	to	FIGO	as	stage	I	tumors	
a	 mean	 level	 of	 oxidized	 guanine	 was	 comparable	 to	 the	 one	
recognized	in	more	clinically	advanced	neoplasms	(46.73±5.62	
vs.	50.82±6.58;	p=0.72).	
As	far	as	8-oxo-7,8-dihydroguanine	distribution	within	cell	
nucleus	 is	 concerned	 type	A	 image	was	 noted	 only	 in	 normal	
endometrium	and	to	a	lesser	degree	in	tumor	tissue,	whereas	type	
B,	C	and	D	were	merely	present	in	adenocarcinomas	(Figure	5).
Figure 1. Digital photography of 11 optical slices of human normal endometrium 
nucleus (2000x magnification). White areas reflect 8-oxo-7,8-dihydroguanine DNA  
lesion distribution.
Figure 3. Mean amount (±SEM) of 8-oxo-7,8-dihydroguanine in normal 
endometrium (NE) and uterine adenocarcinomas (EC); * p<0,001. 
Figure 4. Mean (±SEM) 8-oxo-7,8-dihydroguanine level in uterine adenocarcinomas 
according to WHO grading system in comparison to normal endometrium (NE);  
* p<0,001.
Figure 2. Digital photography of 11 optical slices of human uterine adenocarcinoma 
tissue nucleus (2000x magnification). White areas reflect 8-oxo-7,8-dihydroguanine 
DNA damage distribution.
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Discussion
This	study	shows	for	the	first	time	the	levels	of	8-oxo-7,8-
dihydroguanine	 in	 normal	 endometrium	 and	 sporadic	 uterine	
adenocarcinomas	which	are	widely	known	as	estrogen-dependent	
tissues	 [20].	 In	 the	 presented	 study	 the	 results	 of	 tumors’	
fluorescence	 intensity	 generated	 by	 8-oxo-7,8-dihydroguanine	
were	 compared	 to	 those	 obtained	 in	 endometrium	 collected	
from	cancer-free	women	instead	of	measurements	from	margin	
tissues	 surrounding	 the	neoplasms.	This	 strategy	was	based	on	
the	opinion	 that	 human	neoplastic	 cell	 lines,	 including	ovarian	
carcinoma	that	is	suspected	to	be	estrogen-dependent,	can	release	
in	culture	large	amounts	of	hydrogen	peroxide	that	can	alter	an	
oxidative	level	of	neighboring	disease-free	tissues	[21,	22].
	Therefore,	we	believe	that,	as	revealed	by	us,	the	endometrial	
concentrations	of	oxidized	bases	truly	represent	the	background	
level	of	oxidative	stress,	reflecting	also	the	equilibrium	between	
formation	 and	 repair	 of	 damaged	 DNA	 including	 8-oxoGua.	
According	to	Serviddio	et	al.	the	steady-state	level	of	oxidative	
stress	 in	human	endometrium	 is	also	a	 result	of	an	antioxidant	
defense	system	action	which	involves	the	glutathione	peroxidase	
(GSH-Px)-related	enzymatic	reduction	of	hydrogen	peroxide	and	
lipid	hydroperoxides	by	transformation	of	glutathione	(GSH)	to	
its	oxidized	form	(GSSG)	[23].	
Besides,	 that	 group	 of	 authors	 revealed	 that	 in	 normal	
endometrium	 of	 menstruating	 women	 GSH-Px	 activity	 and	
GSSG	as	a	percentage	of	GSH	were	positively	correlated	with	
plasma	 estradiol	 or	 LH	 concentration.	 They	 also	 discovered	
that	 estradiol	 concentration	 negatively	 correlates	 with	 GSH.	
On	 the	 other	 hand,	 Serviddio’s	 group	 found	 no	 significant	
relationship	between	plasma	progesterone	or	FSH	concentration	
and	oxidative	balance,	although	the	earlier	data	of	Ohwada	et	al.	
[24]	 revealed	 that	GSH-Px	 endometrial	 activity	 in	 spayed	 rats	
treated	with	progesterone	was	lower	than	in	untreated	controls.	
Because	we	did	not	perform	hormonal	estimations	in	our	group	
of	women	we	 can	 only	 suspect	 that	widely	 known	 changes	 of	
blood	estradiol	and	LH	concentrations	along	with	related	to	them	
GSH-Px	activity	and	glutatione	concentration	could	be	the	reason	
of	observed	by	us	considerable	interindividual	differences	in	the	
amount	 of	 8-oxo-7,8-dihydroguanine	 i.	 e.	 oxidative	 stress	 in	
noncancerous	endometrial	tissues.	
Based	on	data	published	by	Musarrat	et	al.	[13]	that	oxidative	
DNA	damage	 correlates	with	 estrogen	 receptors	 (ERs)	 content	
we	 expected	 a	 higher	 amount	 of	 8-oxo-7,8-dihydroguanine	 in	
proliferative	than	in	secretory	endometrium.	That	tissue,	even	in	
premenopausal	women,	contains	a	higher	ERs	concentration	and	
being	in	this	menstrual	cycle	phase	under	high	estrogen	influence	
should	theoretically	display	higher	oxidative	DNA	changes	[25].	
However,	 in	 our	 investigations	 8-oxo-7,8-dihydroguanine	
level	 in	 proliferative	 endometrium	 was	 similar	 to	 the	 one	
revealed	in	secretory	tissue,	although	half	of	women	in	this	group	
were	premenopausal	what,	according	to	Gürdöl	et	al.	[26],	should	
implicate	 lower	 GSH-Px	 activity,	 thus	 impaired	 antioxidant	
defenses.	 In	normal	 endometrium	we	were	able	 to	 recognize	a	
positive	 correlation	 between	 oxidized	 DNA	 adducts	 level	 and	
age	which	 is	a	major	 risk	 factor	 for	endometrial	cancer.	 It	was	
in	contrast	to	Matsui	et	al.	[27]	who	did	not	find	any	relationship	
between	 the	 level	 of	 8-OHdG	 and	 age	 in	 noncancerous	 breast	
tissue	which,	as	endometrium,	is	also	believed	to	be	a	hormone-
dependent	tissue.
Our	 investigations	 indicate	 that	 uterine	 adenocarcinomas	
contained	 a	 significantly	 higher	 level	 of	 8-oxo-7,8-
dihydroguanine	 than	 cancer-free	 normal	 endometrium.	 Such	 a	
relationship	between	oxidized	G	content	 in	 cancer	 and	 cancer-
free	tissue	was	also	revealed	by	Malins	et	al.	[28]	and	Musarrat	
et	al.	[13]	but	in	other	estrogen-dependent	organ	like	breast.	An	
increase	of	8-OHdG	in	DNA	of	neoplastic	tissue	in	comparison	
to	 neighboring	 normal	 tissue	 was	 noted	 by	 Okamoto	 et	 al.	
[29]	 in	 renal-cell	 carcinoma	 and	 Oliva	 et	 al.	 [30]	 in	 sporadic	
colon	 cancers.	However,	Kirkali	 et	 al.	 [31]	 has	 no	 found	 such	
relationship	in	human	colorectal	cancer	lately.
Well-differentiated	 endometrial	 adenocarcinomas	 (G1)	
contained	the	level	of	8-oxoG	only	slightly	higher	 than	control	
endometrium.	 Most	 of	 these	 neoplasms	 (7	 out	 12)	 contained	
concurrent	 atypical	 adenomatous	 hyperplasia	 and	 they	 were	
confined	to	endometrial	mucosa	or	invaded	myometrium	for	less	
than	half	of	its	thickness.	According	to	Ohwada	et	al.	[24]	such	
tumors	always	displayed	high	levels	of	GSH-Px	activity,	thus	we	
believe	that	in	our	investigation	antioxidant	defense	system	could	
probably	prevent	higher	oxidized	base	formation	in	that	series.	
Figure 5. 8-oxo-7,8-dihydroguanine distribution within cell nucleus in normal endometrium (A) and adenocarcinomas tumor tissue (B, C, D). Digital image taken under confocal 
microscope (2000x magnification).
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The	level	of	8-oxo-7,8-dihydroguanine	also	depends	on	its	
removal	 from	DNA	 by	DNA	 repair	 enzymes	 and	 the	 removal	
of	8-oxodGMP	from	the	cellular	nucleotide	pool	what	prevents	
its	 incorporation	 into	 DNA.	 Such	 mechanism	 was	 elegantly	
described	by	Olinski’s	group	in	non-small-cell	lung	cancer	[32].	
However,	 due	 to	 the	 lack	 of	 available	 data	 concerning	 uterine	
carcinogenesis	such	a	contribution	to	the	maintenance	of	8-oxoG	
levels	in	endometrial	cancer	DNA	seems	only	possible.
Moderately-differentiated	 uterine	 adenocarcinomas	
displayed	 the	 highest	 8-oxoGua	 that	 decreased	 in	 poorly-
differentiated	ones.	We	 suspect	 that	 such	 a	 pattern	of	 oxidized	
base	amount	could	be	due	to	several	reasons	including	impairment	
of	antioxidant	defense	system	provoked	by	lowering	of	estrogen-
binding	sites	which	reach	their	minimum	concentration	in	most	
histologically	dedifferentiated	endometrial	adenocarcinomas	[24,	
33].	A	decrease	of	8-oxoG	in	G3	as	compared	to	G2	endometrial	
cancers	may	also	depend	on	dilution	of	DNA	oxidized	adducts	
by	DNA	replication	during	rapid	cell	turnover	in	most	advanced	
cancers	 or	 an	 increase	 of	 removal	 of	 8-oxodGMP	 from	 the	
cellular	nucleotide	pool	by	hMTH1	action.	This	hydrolase	gene	
expression	 was	 increased	 in	 human	 renal-cell	 carcinoma,	 and	
as	 it	was	also	 reported,	more	advanced-stage	 tumors	 showed	a	
higher	level	of	hMTH1	expression	[34].
We	 cannot	 exclude	 that	 8-oxo-7,8-dihydroguanine	 level	
could	 also	 be	 related	 to	 contamination	 of	 cancer	 tissue	 with	
noncancerous	 stromal	 or	 inflammatory	 metaplastic	 cells	 or	
lymphocytes	 which	 all	 of	 them	 display	 different	 oxidative	
potential	[35].	Indeed,	Zbar	et	al.	[36]	revealed	that	about	60%	
of	 clarocellular	 type	 of	 kidney	 cancer	 tissue	 is	 composed	 of	
lymphocytes,	whereas	Yamamoto	et	al.	[37]	discovered	that	the	
quantity	 of	 lymphocytes	 infiltrating	 uterine	 neoplastic	 tumors	
known	 as	 TIL	 –	 Tumor	 Infiltrating	 Lymphocytes	 increased	
proportionally	 to	 cancer	 invasiveness.	 Nowsheen	 et	 al.	 [38]	
believed	 that	 more	 histologically	 homogenous	 tumor	 biopsies	
of	liver,	kidney	or	ovarian	neoplasms	gave	even	more	results	of	
the	quantity	of	oxidatively	induced	clustered	DNA	lesions	than	
colon	and	breast	tumor	specimens	in	which	different	levels	of	the	
lesions	probably	depended	on	the	ratio	of	cancerous	epithelium	
and	normal	fibroblasts.
Neither	 depth	 of	 myometrial	 invasion	 nor	 clinical	
advancement	of	endometrial	adenocarcinomas	or	BMI	and	age	
of	the	cancer	affected	women	had	any	effect	on	8-oxoG	amount	
in	tumor	tissue.	Sparse	data	on	influence	of	some	histo-clinical	
features	 of	 uterine	 neoplasms	 and	 their	 risk	 factors	 on	 the	
oxidized	DNA	adduct	content	is	a	limitation	that	prevents	a	final	
conclusion.	Only	Matsui	et	al.	[27]	reported	that	in	breast	cancers	
other	estrogen	dependent	kind	of	neoplasms,	the	8-oxodG	level,	
was	not	dependent	on	lymph	node	metastasis.	However,	they	were	
able	to	recognize	negative	correlations	of	this	DNA	modification	
content	and	clinical	stage	of	disease	and	lymph	node	status.
We	believe	 that	our	 results	 that	show	different	distribution	
of	 8-oxoG	 in	 nuclei	 can	 represent	 not	 only	 the	 quantitative	
differences	 of	 oxidized	 adduct	 but	 they	 could	 probably	 also	
reflect	 the	 heterogeneity	 of	 the	 investigated	 tissue	 specimens.	
Such	possibilities	 are	 now	under	 intensive	 investigation	 in	 our	
laboratories	and	we	will	be	able	to	publish	our	results	soon.
Conclusion
Our	study	indicates	that	in	endometrial	adenocarcinomas	the	
level	of	8-oxo-7,8-dihydroguanine	cannot	 serve	as	a	marker	of	
the	involvement	of	the	disease.	It	also	suggests	that	accumulation	
of	 the	 oxidized	DNA	 base	may	 contribute	 to	 the	 development	
of	endometrial	neoplasia,	however,	oxidative	DNA	damage	does	
not	seem	to	increase	with	tumor	progression.	
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